# Protein Chip Market > Protein Chip Market Research Report Information By Type (Analytical Microarrays, Functional Protein Microarrays and Reverse Phase Protein Microarrays), By Application (Protein Identification, Clinical Diagnostics, Proteomics and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.71% - **2024:** $ 1,248.53 Million - **2025:** $ 1,332.33 Million - **2035:** $ 2,551.21 Million - **Key Players:** Agilent Technologies (US), Illumina (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), PerkinElmer (US), GE Healthcare (GB), Roche Diagnostics (CH), Merck KGaA (DE), Luminex Corporation (US) **Report ID:** MRFR/HC/9548-HCR · **Pages:** 120 · **Author:** Rahul Gotadki · **Last Updated:** April 22, 2026 **URL:** https://www.marketresearchfuture.com/reports/protein-chip-market-11067 --- ## Market Summary ## **Protein Chip Market Overview** As per MRFR analysis, the Protein Chip Market Size was estimated at 1.25 (USD Billion) in 2024. The Protein Chip Market Industry is expected to grow from 1.33 (USD Billion) in 2025 to 2.39 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.71% during the forecast period (2025 - 2034). Source Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ## **Protein Chip Market Trends** The lifestyle of the people in the modern world has undergone a tremendous change. Alcohol usage, smoking, and drug abuse are becoming more and more common. The modern world also promotes a sedentary lifestyle, which has resulted in a lack of physical activity. Obesity, which is the root cause of many chronic lifestyle diseases, is a result of physical inactivity. The condition has gotten worse due to a lack of activity and a diet high in processed, sugary, and nutrient-poor foods from expanding fast-food retail outlets. Diabetes in the general population is also a result of this diet.  The incidence of cancer is increasing due to environmental factors like air pollution. Every cancer is unique, requiring a tailored or focused strategy to management or therapy. Early cancer diagnosis is the first step in lowering the burden of the disease or stopping its growth in its early stages. The expanding use of protein chips in cancer research and diagnostics can be attributed to rising disease awareness and a strong diagnostic infrastructure. Finding biomarkers in cancer cells is a highly successful and economical process using a protein chip. The identification of biomarkers or protein arrays enables the oncologist to create a successful, patient-specific treatment strategy. As a result, the expansion of the worldwide protein chip market CAGR will be fueled by the rising incidence and prevalence of cancer. Protein is present in all organisms. The primary cornerstone of any medical study is an understanding of protein organisation, structure, and interactions with other elements and the environment. The scientific community can solve problems relating to the human body or the living world by having a better grasp of proteins. It teaches students to comprehend the biological processes, illnesses, infections, diseases, disorders, and viruses that occur within the human body more thoroughly. With a greater grasp of the issue, many illnesses and problems can be avoided or addressed.  The development of protein chip technology has the potential to advance medical research in the areas of illness monitoring, drug discovery, prognosis, and other pertinent areas. The usefulness of protein chips in illness diagnosis, disease monitoring, vaccine research, and therapeutic development during the COVID-19 pandemic is a prime illustration of this technology's promise in medicine. Growing demand for protein chips has prompted both public and private market participants to invest more in research and development, creating attractive potential for the market's growth throughout the forecast period. Thus, driving the protein chip market revenue. ## **Protein Chip Market Segment Insights** ### **Protein Chip Type Insights** The protein chip market segmentation, based on type includes Analytical Microarrays, Functional Protein Microarrays and Reverse Phase Protein Microarrays. The analytical microarrays segment dominated the market. A complicated mixture of proteins is profiled using analytical protein microarrays to identify their binding affinities. With the aid of analytical microarrays, the specifics and amounts of protein expression are also examined. Research on antibodies, aptamers, or affibodies is done using analytical protein microarrays. But the main and most important application of it is to research antibodies, which are crucial for tracking illness progression and developing new medications. **Figure 1  Protein Chip Market, by Type, 2022 & 2032 (USD Billion)** **** **_Source Secondary Research, Primary Research, MRFR Database and Analyst Review_** ### **Protein Chip Application Insights** The protein chip market segmentation, based on application, includes Protein Identification, Clinical Diagnostics, Proteomics and Others. The proteomics category generated the most income. Due to the usage of proteomics in conduction chip-based drug discovery investigations and biomedical research, the market is anticipated to continue expanding steadily. The market for protein chips as a whole has a market share of 50%. Spectroscopy, X-ray crystallography, and chromatography are a few of the many applications it can be used for. ### **Protein Chip End User Insights** The protein chip market segmentation, based on end user includes Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies. The academic & research institutes segment dominated the market. DNA microarrays are being gradually replaced in several fields by protein chips, a novel technology. Protein chips have been used to get around the DNA microarray's limitations in terms of protein expression and profiling. Over the past ten years, the potential of protein chips in cancer, diagnosis, drug monitoring, drug development, targeted therapy or treatment, and personalized medicine has received significant attention. **Protein Chip Regional Insights** By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American protein chip market area will dominate this market as a result of the increased cancer incidence. Given the sedentary lifestyle, excessive intake of processed sugary foods, and lack of physical activity, the prevalence is rising, which can be ascribed to the rising obese population. The increased cancer incidence in the area is due to both excessive alcohol use and smoking. The expansion of the regional market is further aided by the presence of significant industrial players and top academic and research institutions. Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil. **Figure 2  PROTEIN CHIP MARKET SHARE BY REGION 2022 (USD Billion)** **** **_Source Secondary Research, Primary Research, MRFR Database and Analyst Review_** Europe protein chip market accounts for the second-largest market share. The growth of the market has been fueled by the development of high-quality healthcare and an increase in cancer incidence as a result of population growth. As a result of this method's numerous applications, governments are becoming more interested in it. Therefore, government actions will increase the trust of research centers in the area. Further, the German protein chip market held the largest market share, and the UK protein chip market was the fastest growing market in the European region The Asia-Pacific Protein chip Market is expected to grow at the fastest CAGR from 2023 to 2032 due to the region's growing need for technical innovation combined with the increased occurrence of infections, diseases, and cancer cases. Additionally, the population increase in nations like China and India is the main driver of the growth. The region's increasing sickness cases that require diagnosis are another factor driving the market's growth. Moreover, China’s protein chip market held the largest market share, and the Indian protein chip market was the fastest growing market in the Asia-Pacific region. **Protein Chip Key Market Players & Competitive Insights** Leading market players are investing heavily in research and development in order to expand their product lines, which will help the protein chip market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, protein chip industry must offer cost-effective items. Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  protein chip industry to benefit clients and increase the market sector. In recent years, the protein chip industry has offered some of the most significant advantages to market. Major players in the protein chip market attempting to increase market demand by investing in research and development operations include Sengenics (US), Thermo Fisher Scientific Inc (US), Microarrays Inc (US), Agilent Technologies Inc (US), Bio-Rad Laboratories Inc (US), Full Moon BioSystems Inc (US), CDI Laboratories Inc (US), OriGene Technologies Inc (US) and Innopsys (France). In order to build the largest commercial collection of full-length human cDNAs in a common expression vector, OriGene Technologies was established as a provider of research tools. System biology techniques have made it possible to identify pertinent therapeutic targets thanks to the availability of the whole human genome sequence and the subsequent development of genome-based technologies. The goal of OriGene is to develop comprehensive, genome-wide research tools and technological platforms that will allow researchers to examine entire biological pathways and, in turn, gain a better knowledge of how diseases, such as cancer, work. Private firm Innopsys specialises in the creation and marketing of software and scanners for fluorescence confocal microscopy. InnoScan, a full-range microarray scanner, and Mapix, an image analysis programme, are now being marketed by the business. The InnoScan System product line combines sensitivity, speed, and resolution (up to 0.5 m/pixel) and is compatible with all types of microarrays. **Key Companies in the protein chip market include** ### Protein Chip Market Industry Developments - **Q2 2024: Agilent Technologies Introduces ProteoAnalyzer System for Protein Quality Assessment** Agilent Technologies launched the ProteoAnalyzer System, a next-generation solution designed to enhance analytical precision in proteomics and support high-throughput protein chip applications. ## **Protein Chip Market Segmentation** ### **Protein Chip Type Outlook (USD Billion, 2018-2032)** ### **Protein Chip Application Outlook (USD Billion, 2018-2032)** ### **Protein Chip End User Outlook (USD Billion, 2018-2032)** ### **Protein Chip Regional Outlook (USD Billion, 2018-2032)** ## Market Drivers ### Market Trends and Growth Projections The Global Protein Chip Market Industry is characterized by dynamic trends and growth projections that reflect its evolving landscape. The market is anticipated to grow from 1.25 USD Billion in 2024 to 2.55 USD Billion by 2035, indicating a robust trajectory. The compound annual growth rate of 6.7% from 2025 to 2035 suggests that the industry is poised for sustained growth, driven by technological advancements, increasing applications in various fields, and heightened investment in research. These trends underscore the importance of protein chips in addressing contemporary challenges in healthcare and biotechnology. ### Rising Prevalence of Chronic Diseases The Global Protein Chip Market Industry is also being propelled by the rising prevalence of chronic diseases, which necessitate advanced diagnostic and monitoring tools. Protein chips offer a promising solution for the early detection and management of conditions such as cancer, diabetes, and cardiovascular diseases. As healthcare systems worldwide strive to improve patient outcomes, the demand for innovative diagnostic technologies is likely to increase. This trend is expected to contribute to the market's growth, with projections indicating a significant expansion in the coming years. The ability of protein chips to provide rapid and accurate results positions them as essential tools in modern healthcare. ### Rising Demand for Personalized Medicine The Global Protein Chip Market Industry is experiencing a surge in demand for personalized medicine, driven by advancements in genomics and proteomics. As healthcare shifts towards tailored treatments, protein chips play a crucial role in biomarker discovery and patient stratification. This trend is reflected in the projected market growth, with the industry expected to reach 1.25 USD Billion in 2024. Personalized medicine not only enhances treatment efficacy but also minimizes adverse effects, making it a focal point for healthcare providers and researchers alike. The integration of protein chips into clinical workflows is likely to accelerate, further propelling market expansion. ### Increased Investment in Biotechnology Research Investment in biotechnology research is a significant driver of the Global Protein Chip Market Industry. Governments and private entities are allocating substantial funds to support research initiatives that leverage protein chips for various applications, including diagnostics and therapeutic development. This influx of capital is likely to enhance research capabilities and foster innovation within the industry. As a result, the market is expected to benefit from a robust pipeline of new products and technologies. The emphasis on biotechnology research aligns with global health priorities, suggesting that the protein chip market will continue to thrive as funding and interest in this sector grow. ### Technological Advancements in Protein Chip Technology Technological innovations are significantly influencing the Global Protein Chip Market Industry. Enhanced sensitivity, specificity, and multiplexing capabilities of protein chips are enabling researchers to conduct high-throughput analyses with greater accuracy. For instance, the development of microarray technology has revolutionized protein profiling, allowing for the simultaneous detection of thousands of proteins. As these technologies evolve, they are expected to drive market growth, with projections indicating a market size of 2.55 USD Billion by 2035. The continuous improvement in chip design and manufacturing processes suggests that the industry will likely witness increased adoption across various research and clinical applications. ### Growing Applications in Drug Discovery and Development The Global Protein Chip Market Industry is witnessing increased applications in drug discovery and development, as protein chips facilitate the identification of potential drug targets and biomarkers. Pharmaceutical companies are increasingly utilizing these tools to streamline their research processes, thereby reducing time and costs associated with drug development. The integration of protein chips into high-throughput screening platforms is becoming more prevalent, which could lead to a compound annual growth rate of 6.7% from 2025 to 2035. This growth trajectory indicates that the industry is poised for substantial expansion as the demand for efficient drug discovery methods continues to rise. ## Future Outlook The Protein Chip Market is projected to grow at a 6.71% CAGR from 2025 to 2035, driven by advancements in personalized medicine, increasing demand for rapid diagnostics, and technological innovations. **New opportunities:** - Development of integrated protein chip platforms for personalized healthcare solutions. Expansion into emerging markets with tailored protein chip applications. Collaboration with biotech firms for innovative protein biomarker discovery. By 2035, the Protein Chip Market is expected to achieve substantial growth, solidifying its role in advanced diagnostics. ## Segment Insights ### By Application: Disease Diagnosis (Largest) vs. Personalized Medicine (Fastest-Growing) Within the Protein Chip Market, the application segment is prominently led by Disease Diagnosis, which captures the largest market share due to its vital role in clinical settings and the growing need for rapid and accurate diagnostic tools. Following this is Personalized Medicine, which, while currently smaller in overall market share, is recognized for its innovative approach to tailoring treatments to individual patient profiles, indicating a significant shift in healthcare dynamics. Moreover, Drug Discovery and Genetic Research are also integral to this segment but hold comparatively lesser market positions. The growth trend for Personalized Medicine is particularly pronounced as advancements in technology promote more targeted treatment methodologies, driven by an increasing demand for individualized healthcare solutions. Disease Diagnosis continues to evolve with refined methodologies, enhancing the accuracy and efficiency of patient assessments, thereby solidifying its market presence. Disease Diagnosis (Dominant) vs. Drug Discovery (Emerging) Disease Diagnosis stands out as the dominant application in the Protein Chip Market. It leverages advanced protein profiling technologies to facilitate fast and accurate identification of various health conditions, thus playing a critical role in improving patient outcomes. In contrast, Drug Discovery, categorized as an emerging application, focuses on utilizing protein chips to explore new therapeutic compounds and biomarkers for disease treatment. This segment is gaining traction as pharmaceutical companies strive to accelerate the drug development process. The incorporation of protein chips into the drug development pipeline enhances the identification of potential drug candidates, contributing to the momentum of this emerging segment. Both areas showcase their unique contributions to medical science, with Disease Diagnosis maintaining robust stability, while Drug Discovery offers promising growth potential. ### By Technology: Microarray Technology (Largest) vs. Mass Spectrometry (Fastest-Growing) The Protein Chip Market is categorized into several technology segments, with Microarray Technology currently leading in market share. This segment benefits from widespread adoption due to its versatility and ability to analyze multiple targets simultaneously. Following closely is Mass Spectrometry, which is rapidly gaining traction owing to its high sensitivity and accuracy in protein analysis. Other technologies like [Surface Plasmon Resonance](https://www.marketresearchfuture.com/reports/surface-plasmon-resonance-market-19209) and Electrochemical Detection play significant roles, but their market shares remain smaller compared to the top two. Technology: Microarray Technology (Dominant) vs. Mass Spectrometry (Emerging) Microarray Technology remains the dominant force in the Protein Chip Market, leading due to its well-established applications in genomics and proteomics. Its capability to handle large datasets and provide high-throughput analysis makes it preferred in research and clinical labs. In contrast, Mass Spectrometry is an emerging technology that is revolutionizing protein analysis by offering unparalleled precision and the ability to identify post-translational modifications. As research becomes more advanced, the demand for accurate and efficient protein analysis drives the adoption of Mass Spectrometry at an increasing rate, heralding its rising importance in the market. ### By End User: Pharmaceutical Companies (Largest) vs. Academic Research Institutes (Fastest-Growing) The Protein Chip Market showcases a diverse distribution of market share among its end users, primarily comprising pharmaceutical companies, biotechnology firms, academic research institutes, and clinical laboratories. Currently, pharmaceutical companies hold the largest market share, driven by their investments in drug development and personalized medicine. Academic research institutes, however, are rapidly increasing their share, attributed to their focus on groundbreaking research that leverages protein chip technology for biomolecular analysis. Pharmaceutical Companies (Dominant) vs. Academic Research Institutes (Emerging) Pharmaceutical companies stand out as dominant players in the Protein Chip Market due to their robust financial resources and extensive R&D capabilities. They leverage protein chips to expedite drug discovery and development, leading to more efficient and targeted therapeutic solutions. Conversely, academic research institutes are emerging as significant contributors to the market. These institutions adopt protein chips to enhance their research capabilities, focusing on proteomics and diagnostics. Their innovative approaches are fostering collaborations with biotech firms, thereby further driving advancements in the field. ## Regional Market Share Analysis ### North America : Market Leader in Innovation North America continues to lead the Protein Chip Market, holding a significant share of 624.27 million in 2024. The region's growth is driven by advanced research facilities, increasing investments in biotechnology, and a robust regulatory framework that supports innovation. The demand for personalized medicine and diagnostics is also on the rise, further propelling market expansion. The United States is the primary contributor, with key players like Agilent Technologies, Illumina, and Thermo Fisher Scientific dominating the landscape. The competitive environment is characterized by continuous technological advancements and strategic collaborations among leading firms, ensuring a strong foothold in the global market. ### Europe : Emerging Market with Potential Europe's Protein Chip Market is valued at 348.56 million, reflecting a growing interest in personalized healthcare solutions. The region benefits from strong governmental support for research and development, alongside increasing collaborations between academic institutions and industry players. Regulatory frameworks are evolving to facilitate innovation, which is crucial for market growth. Germany, the UK, and France are leading countries in this sector, with companies like Roche Diagnostics and Merck KGaA playing pivotal roles. The competitive landscape is marked by a mix of established firms and emerging startups, all striving to enhance their product offerings and expand their market presence. ### Asia-Pacific : Rapid Growth and Development The Asia-Pacific region, valued at 227.45 million, is witnessing rapid growth in the Protein Chip Market, driven by increasing healthcare expenditures and a rising focus on research and development. Countries like China and India are investing heavily in biotechnology, which is expected to boost market demand significantly. Regulatory bodies are also becoming more supportive of innovative healthcare solutions, further catalyzing growth. China is emerging as a key player, with numerous local companies entering the market. The competitive landscape is evolving, with both domestic and international firms vying for market share. Key players like Illumina and Thermo Fisher Scientific are expanding their operations in the region to capitalize on the growing demand. ### Middle East and Africa : Untapped Market Opportunities The Middle East and Africa region, with a market size of 48.25 million, presents untapped opportunities in the Protein Chip Market. The growth is primarily driven by increasing investments in healthcare infrastructure and a rising awareness of advanced diagnostic technologies. Governments are beginning to recognize the importance of biotechnology, leading to supportive policies that encourage innovation. Countries like South Africa and the UAE are at the forefront of this development, with a growing number of research initiatives and collaborations. The competitive landscape is still in its nascent stages, but the presence of global players is expected to stimulate growth and attract local investments. ## Competitive Benchmarking The Protein Chip Market is currently characterized by a dynamic competitive landscape, driven by advancements in biotechnology and increasing demand for personalized medicine. Key players such as Agilent Technologies (US), Illumina (US), and Thermo Fisher Scientific (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Agilent Technologies (US) focuses on expanding its product portfolio through continuous research and development, while Illumina (US) emphasizes its leadership in genomic sequencing technologies. Thermo Fisher Scientific (US) adopts a strategy of mergers and acquisitions to bolster its capabilities, thereby shaping a competitive environment that is increasingly reliant on technological advancements and collaborative efforts. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The Protein Chip Market appears moderately fragmented, with a mix of established players and emerging companies. The collective influence of these key players is significant, as they drive innovation and set industry standards, which in turn influences market dynamics and consumer expectations. In November 2025, Illumina (US) announced a strategic partnership with a leading pharmaceutical company to develop a new protein chip technology aimed at accelerating drug discovery. This collaboration is expected to enhance Illumina's capabilities in precision medicine, allowing for more targeted therapies and potentially revolutionizing the drug development process. The strategic importance of this partnership lies in its potential to position Illumina as a leader in the integration of protein chips within the pharmaceutical sector. In October 2025, Thermo Fisher Scientific (US) launched a new line of protein chips designed for high-throughput screening applications. This product introduction is significant as it addresses the growing demand for rapid and efficient screening methods in research and clinical settings. By enhancing its product offerings, Thermo Fisher aims to capture a larger market share and respond to the evolving needs of researchers and clinicians. In September 2025, Agilent Technologies (US) expanded its global footprint by establishing a new manufacturing facility in Asia. This move is indicative of Agilent's strategy to localize production and reduce lead times for customers in the region. The establishment of this facility not only enhances Agilent's operational capabilities but also reflects a broader trend of companies seeking to optimize their supply chains in response to global market demands. As of December 2025, current competitive trends in the Protein Chip Market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and the ability to deliver customized solutions. This shift underscores the importance of agility and responsiveness in a rapidly changing market. ## Recent News & Developments - **Q2 2024: Agilent Technologies Introduces ProteoAnalyzer System for Protein Quality Assessment** Agilent Technologies launched the ProteoAnalyzer System, a next-generation solution designed to enhance analytical precision in proteomics and support high-throughput protein chip applications. ## Report Scope | MARKET SIZE 2024 | 1248.53(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1332.33(USD Million) | | MARKET SIZE 2035 | 2551.21(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.71% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Agilent Technologies (US), Illumina (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), PerkinElmer (US), GE Healthcare (GB), Roche Diagnostics (CH), Merck KGaA (DE), Luminex Corporation (US) | | Segments Covered | Application, Technology, End User | | Key Market Opportunities | Advancements in personalized medicine drive demand for innovative solutions in the Protein Chip Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Protein Chip Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Protein Chip Market as of 2025?** A: The Protein Chip Market is valued at approximately 1248.53 USD Million in 2024. **Q: What is the projected market size for the Protein Chip Market by 2035?** A: The market is expected to reach a valuation of 2551.21 USD Million by 2035. **Q: What is the expected CAGR for the Protein Chip Market during the forecast period 2025 - 2035?** A: The anticipated CAGR for the Protein Chip Market during 2025 - 2035 is 6.71%. **Q: Which application segment is projected to have the highest growth in the Protein Chip Market?** A: The Disease Diagnosis segment is projected to grow from 400.0 to 800.0 USD Million during the forecast period. **Q: How does the Drug Discovery segment perform in the Protein Chip Market?** A: The Drug Discovery segment is expected to increase from 300.0 to 600.0 USD Million by 2035. **Q: What technologies are driving the Protein Chip Market growth?** A: Microarray Technology is leading, with a projected growth from 499.0 to 1020.0 USD Million. **Q: Which end-user segment is likely to dominate the Protein Chip Market?** A: Pharmaceutical Companies are expected to dominate, growing from 500.0 to 1000.0 USD Million. **Q: What role do key players like Agilent Technologies and Illumina play in the market?** A: Key players such as Agilent Technologies and Illumina are instrumental in driving innovation and market growth. **Q: What is the expected performance of the Surface Plasmon Resonance technology in the market?** A: Surface Plasmon Resonance technology is projected to grow from 250.0 to 500.0 USD Million by 2035. **Q: How does the Protein Chip Market support personalized medicine?** A: The Personalized Medicine segment is anticipated to grow from 298.53 to 651.21 USD Million during the forecast period. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/protein-chip-market-11067*